DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-0.26%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.46B
AUM Growth
+$2.46B
(+9.7%)
Cap. Flow
+$265M
Cap. Flow
% of AUM
10.77%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
159
New
39
Increased
41
Reduced
16
Closed
31
Top Buys
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$102M |
| 2 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$36.4M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$23.8M |
| 4 |
HCA Healthcare
HCA
|
$21.8M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$20.7M |
Sector Composition
| 1 | Healthcare | 52.22% |
| 2 | Financials | 3.28% |
| 3 | Technology | 0.61% |
| 4 | Industrials | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUXL
1
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $187M | 6.82% | 6,267,382 | – | – |
|
|
AGN
2
DELISTED
ALLERGAN INC
AGN
| $87.6M | 3.19% | 491,399 +57,200 | +13% | +$10.2M |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $80.6M | 2.94% | 6,141,094 +1,241,373 | +25% | +$16.3M |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $75.2M | 2.74% | 5,258,475 | – | – |
|
5
Adverum Biotechnologies
ADVM
$64.6M
| $70M | 2.55% | +2,047,679 | New | +$70M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $67.8M | 2.47% | 5,520,566 +4,907,779 | +801% | +$60.3M |
|
|
ASPX
7
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $64.5M | 2.35% | 2,512,160 +528,122 | +27% | +$13.6M |
|
8
eHealth
EHTH
$118M
| $54.6M | 1.99% | 2,264,588 +941,197 | +71% | +$22.7M |
|
|
INFI
9
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $52.1M | 1.9% | 3,882,805 +207,967 | +6% | +$2.79M |
|
|
UAM
10
DELISTED
Universal American Corp
UAM
| $48.2M | 1.76% | 5,994,518 +222,781 | +4% | +$1.79M |
|
|
AERI
11
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $48.1M | 1.75% | 2,324,917 +974,067 | +72% | +$20.2M |
|
12
DaVita
DVA
$9.85B
| $47M | 1.71% | 642,425 +75,837 | +13% | +$5.55M |
|
|
MNK
13
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $46M | 1.68% | +510,791 | New | +$46M |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $45.2M | 1.65% | 1,258,687 +183,419 | +17% | +$6.58M |
|
15
AbbVie
ABBV
$372B
| $44.3M | 1.61% | 766,400 +225,000 | +42% | +$13M |
|
|
ARRY
16
DELISTED
Array Biopharma Inc
ARRY
| $43.6M | 1.59% | 12,205,673 | – | – |
|
|
DRNA
17
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $30.9M | 1.13% | 2,428,569 | – | – |
|
|
DYAX
18
DELISTED
DYAX CORPORATION
DYAX
| $29.9M | 1.09% | 2,954,684 -762,329 | -21% | -$7.71M |
|
|
KITE
19
DELISTED
Kite Pharma, Inc.
KITE
| $28.8M | 1.05% | +1,011,998 | New | +$28.8M |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $28.6M | 1.04% | +482,000 | New | +$28.6M |
|
21
Insmed
INSM
$28.8B
| $27.1M | 0.99% | 2,080,160 +874,926 | +73% | +$11.4M |
|
|
ELGX
22
DELISTED
Endologix Inc
ELGX
| $26.5M | 0.97% | 2,501,526 +1,019,598 | +69% | +$10.8M |
|
23
Globus Medical
GMED
$8.27B
| $25.1M | 0.92% | +1,278,235 | New | +$25.1M |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $24.5M | 0.89% | 5,847,999 +1,478,933 | +34% | +$6.2M |
|
|
XNPT
25
DELISTED
XENOPORT, INC.
XNPT
| $23.9M | 0.87% | 4,438,882 +11,240 | +0.3% | +$60.5K |
|